Section of Hematology/Oncology, Department of Medicine, The University of Chicago, 5841 S. Maryland Avenue, MC 2115 Chicago, Illinois 60637, USA.
Nat Rev Cancer. 2015 Feb;15(2):110-24. doi: 10.1038/nrc3884.
Several protein lysine methyltransferases and demethylases have been identified to have critical roles in histone modification. A large body of evidence has indicated that their dysregulation is involved in the development and progression of various diseases, including cancer, and these enzymes are now considered to be potential therapeutic targets. Although most studies have focused on histone methylation, many reports have revealed that these enzymes also regulate the methylation dynamics of non-histone proteins such as p53, RB1 and STAT3 (signal transducer and activator of transcription 3), which have important roles in human tumorigenesis. In this Review, we summarize the molecular functions of protein lysine methylation and its involvement in human cancer, with a particular focus on lysine methylation of non-histone proteins.
已鉴定出几种蛋白质赖氨酸甲基转移酶和去甲基酶,它们在组蛋白修饰中具有关键作用。大量证据表明,它们的失调与各种疾病(包括癌症)的发展和进展有关,这些酶现在被认为是潜在的治疗靶点。尽管大多数研究都集中在组蛋白甲基化上,但许多报道表明,这些酶还调节非组蛋白蛋白(如 p53、RB1 和 STAT3(信号转导和转录激活因子 3))的甲基化动力学,它们在人类肿瘤发生中具有重要作用。在这篇综述中,我们总结了蛋白质赖氨酸甲基化的分子功能及其在人类癌症中的作用,特别关注非组蛋白蛋白的赖氨酸甲基化。